Michael A. Schwarzschild MD, PhD

Dr. Schwarzschild is a Professor of Neurology at Harvard Medical School and Attending Neurologist at Massachusetts General Hospital. He completed undergraduate training in biochemistry at Princeton University. He went on to medical, and graduate neuroscience training at Harvard Medical School to write his PhD thesis on the neurochemistry of tyrosine hydroxylase, the enzyme controlling dopamine biosynthesis. His neurology residency and Parkinson's disease fellowship training were at the Massachusetts General Hospital. Michael has been the recipient of a Cotzias Fellowship from the American Parkinson's Disease Association and a Paul Beeson Physician Faculty Scholar Award in Aging Research. He has led disease progression studies of the PSG, a consortium of North American clinical trial sites and investigators dedicated to finding improved treatments for Parkinson’s. In 2012, he was elected to lead the PSG, now headquartered in the Massachusetts General Hospital Neurology Department. He works with Parkinson's patients and their families in his weekly movement disorders clinic at MGH.